Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dolors Soy

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 14, 2020
Continuous learning through platformsDolors Soy-Muner
Enfermedades Infecciosas Y Microbiologia Clinica|December 2, 2011
[Antibiotic dose adjustment in the treatment of MRSA infections in patients with acute renal failure undergoing continuous renal replacement therapies]Esther Carcelero, Dolors Soy
Current Opinion in Critical Care|September 1, 2006
Antibacterial dosage in intensive-care-unit patients based on pharmacokinetic/pharmacodynamic principlesDolors Soy, Antoni Torres
European Journal of Hospital Pharmacy : Science and Practice|July 18, 2025
Impact of using different renal function estimation equations on vancomycin dosingLaura Gratacós, Dolors Soy-Muner
Therapeutic Drug Monitoring|December 14, 2006
Teicoplanin population pharmacokinetic analysis in hospitalized patientsDolors Soy, Ester López, Josep Ribas
Expert Opinion on Drug Safety|April 3, 2020
The safety of antimicrobials for the treatment of community-acquired pneumoniaCarla Bastida, Dolors Soy, Antoni Torres
Medicina Clinica|June 23, 2004
[Pharmacokinetic interaction between valproic acid and meropenem]Ana Pérez Plasencia, Dolors Soy, Josep M Nicolas
European Journal of Hospital Pharmacy : Science and Practice|December 16, 2025
Evaluation of impact of clinical variables on enoxaparin dosing and anti-Xa factor concentrationArnau Torrent-Rodríguez, Carla Bastida, Dolors Soy-Muner
Medicina Clinica|October 3, 2012
[Flecainide intoxication]Santiago Nogué, Juan Cino, Nuria Corominas, et al.
Clinical Pharmacology and Therapeutics|November 13, 2004
Population one-compartment pharmacokinetic analysis with missing dosage dataDolors Soy, Stuart L Beal, Lewis B Sheiner
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 14, 2020
Continuous learning through platformsDolors Soy-Muner
Enfermedades Infecciosas Y Microbiologia Clinica|December 2, 2011
[Antibiotic dose adjustment in the treatment of MRSA infections in patients with acute renal failure undergoing continuous renal replacement therapies]Esther Carcelero, Dolors Soy
Current Opinion in Critical Care|September 1, 2006
Antibacterial dosage in intensive-care-unit patients based on pharmacokinetic/pharmacodynamic principlesDolors Soy, Antoni Torres
European Journal of Hospital Pharmacy : Science and Practice|July 18, 2025
Impact of using different renal function estimation equations on vancomycin dosingLaura Gratacós, Dolors Soy-Muner
Therapeutic Drug Monitoring|December 14, 2006
Teicoplanin population pharmacokinetic analysis in hospitalized patientsDolors Soy, Ester López, Josep Ribas
Expert Opinion on Drug Safety|April 3, 2020
The safety of antimicrobials for the treatment of community-acquired pneumoniaCarla Bastida, Dolors Soy, Antoni Torres
Medicina Clinica|June 23, 2004
[Pharmacokinetic interaction between valproic acid and meropenem]Ana Pérez Plasencia, Dolors Soy, Josep M Nicolas
European Journal of Hospital Pharmacy : Science and Practice|December 16, 2025
Evaluation of impact of clinical variables on enoxaparin dosing and anti-Xa factor concentrationArnau Torrent-Rodríguez, Carla Bastida, Dolors Soy-Muner
Medicina Clinica|October 3, 2012
[Flecainide intoxication]Santiago Nogué, Juan Cino, Nuria Corominas, et al.
Clinical Pharmacology and Therapeutics|November 13, 2004
Population one-compartment pharmacokinetic analysis with missing dosage dataDolors Soy, Stuart L Beal, Lewis B Sheiner
Pageof 12